Loading...
Sodium‐glucose co‐transporter‐2 inhibitors and susceptibility to COVID‐19: A population‐based retrospective cohort study
Sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors are widely prescribed in people with type 2 diabetes. We aimed to investigate whether SGLT2 inhibitor prescription is associated with COVID‐19, when compared with an active comparator. We performed a propensity‐score‐matched cohort study with active...
Saved in:
| Published in: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Blackwell Publishing Ltd
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537530/ https://ncbi.nlm.nih.gov/pubmed/32991065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14203 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|